Delavirdine mesylate (U-90152)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Delavirdine mesylate (U-90152), covering 2021-11-04 to 2021-11-04. Get the full timeline:
Most recent: Clinical Trial Update: A Phase II Double-Blind Study of Delavirdine Mesylate ( U-90152 ) in Combination With Zidovudine ( AZT ) and/or Didanosine ( ddI ) Versus AZT and ddI Combination Therapy [Phase 2]